Skip to main content
IC
Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
0.9700
+0.1700 (21.25%)
May 12, 2025, 4:00 PM EDT

Silence Therapeutics Revenue

Silence Therapeutics had revenue of $142.00K in the quarter ending March 31, 2025, a decrease of -99.09%. This brings the company's revenue in the last twelve months to $27.70M, down -16.00% year-over-year. In the year 2024, Silence Therapeutics had annual revenue of $43.26M with 36.71% growth.

Revenue (ttm)
27.70M
Revenue Growth
-16.00%
P/S Ratio
6.53
Revenue / Employee
238.80K
Employees
116
Market Cap
180.87M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202443.26M11.62M36.71%
Dec 31, 202331.64M9.99M46.12%
Dec 31, 202221.66M4.84M28.82%
Dec 31, 202116.81M9.33M124.73%
Dec 31, 20207.48M7.16M2,214.81%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.73B
Veradigm 588.02M
Tian'an Technology Group 1.78M
Glass House Brands 200.90M
Elite Pharmaceuticals 70.00M
Northwest Biotherapeutics 1.38M
BioStem Technologies 301.83M
American Oncology Network 1.76B
Revenue Rankings

Silence Therapeutics News

More News